For example, there is a significantly higher level of vasoactive intestinal peptide (VIP) receptor expression in the BCSC population as compared to the bulk cancer cells, which makes the VIP a potential active targeting moiety to achieve high anti-BCSC activity (Gülçür et al., 2013). Here, VIP is linked to cancer.